Reuters logo
BRIEF-Boehringer Ingelheim and Eli Lilly collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes
September 25, 2017 / 1:15 PM / 3 months ago

BRIEF-Boehringer Ingelheim and Eli Lilly collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes

Sept 25 (Reuters) - Eli Lilly and Co:

* Geisinger and Boehringer Ingelheim and its diabetes alliance Eli Lilly collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below